Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × Ipilimumab × 30 days × Clear all

Sponsor

Conditions

Melanoma 17 Carcinoma, Renal Cell 12 Carcinoma, Non-Small-Cell Lung 7 Neoplasm Metastasis 6 Squamous Cell Carcinoma of Head and Neck 4 Skin Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Kidney Neoplasms 3 Glioblastoma 3 Carcinoma, Merkel Cell 3 Brain Neoplasms 3 Uveal Melanoma 2 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Gliosarcoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2

Interventions

Cyclophosphamide 19 fludarabine 14 fludarabine phosphate 10 Vincristine 10 Methotrexate 9 venetoclax 8 Melphalan 8 Granulocyte Colony-Stimulating Factor 8 Filgrastim 8 blinatumomab 7 Whole-Body Irradiation 7 Dexamethasone 7 Cytarabine 7 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Mycophenolic Acid 5 Mesna 5 Doxorubicin 5 Calcium Dobesilate 5 ponatinib 4 merphos 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 calaspargase pegol 4 Thiotepa 4 Tacrolimus 4 Specimen Handling 4 Rituximab 4 Prednisone 4 Peripheral Blood Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡